The non-surgical procedures market offers a diverse range of products categorized into injectables, non-injectables, facial rejuvenation, nonsurgical skin tightening, microdermabrasion, laser skin resurfacing, and others. These interventions utilize materials of both natural and synthetic origins, catering to various patient needs. With a focus on facial aesthetics and skin enhancement, the market showcases a broad spectrum of non-invasive solutions. The utilization of both natural and synthetic materials underscores the versatility and advancement in non-surgical procedures, meeting diverse aesthetic and cosmetic requirements.
Access Full Report @ https://www.databridgemarketresearch.com/fr/reports/global-non-surgical-procedures-market
Data Bridge Market Research analyses that the Global Non-Surgical Procedures Market which was USD 61,200.00 million in 2022, is expected to reach USD 192,485.44 million by 2030, and is expected to undergo a CAGR of 15.4% during the forecast period of 2023-2030. The non-surgical procedures market is driven by a growing preference for treatments with shorter recovery times and reduced risks. Patients seek minimally invasive options that allow quicker recovery, encouraging the adoption of non-surgical procedures for aesthetic enhancements with minimal downtime and risks.
Key Findings of the Study
Aging population is expected to drive the market's growth rate
The non-surgical procedures market is fueled by the growing aging demographic, intensifying the demand for non-surgical anti-aging treatments. As people age, there is a heightened interest in aesthetic solutions that offer rejuvenation without the invasiveness of surgery. Non-surgical procedures provide effective alternatives to address age-related concerns, such as wrinkles and sagging skin. This demographic shift towards non-invasive anti-aging solutions propels market growth, reflecting a preference for natural-looking and gradual enhancements.
Report Scope and Market Segmentation
Report Metric
|
Details
|
Forecast Period
|
2023 to 2030
|
Base Year
|
2022
|
Historic Years
|
2021 (Customizable to 2015-2020)
|
Quantitative Units
|
Revenue in USD Million, Volumes in Units, Pricing in USD
|
Segments Covered
|
Product Type (Injectable, Non-Injectables, Facial Rejuvenation, Nonsurgical Skin Tightening, Microdermabrasion, Laser Skin Resurfacing, Others), Material Type (Natural and Synthetic), Gender (Male and Female), Usability (Professional Use and Direct Patient), Indication (Skin Lightening, Facial Aesthetic, Body Contouring, Reconstructive and Others), Procedure (Body Care, Face Care, Skin Care), Practicians (Dermatologists, Aesthetic Doctors, Plastic Surgeons, Independent Aesthetic Professionals, Others), Service Provider (Hospitals, Medical Spas and Beauty Centers, Cosmetic Centers, Dermatology Clinics, Homecare Setting and Others), Distribution Channel (Direct Tender and Retail Sales)
|
Countries Covered
|
U.S., Canada and Mexico in North America, Germany, France, U.K., Netherlands, Switzerland, Belgium, Russia, Italy, Spain, Turkey, Rest of Europe in Europe, China, Japan, India, South Korea, Singapore, Malaysia, Australia, Thailand, Indonesia, Philippines, Rest of Asia-Pacific (APAC) in the Asia-Pacific (APAC), Saudi Arabia, U.A.E, South Africa, Egypt, Israel, Rest of Middle East and Africa (MEA) as a part of Middle East and Africa (MEA), Brazil, Argentina and Rest of South America as part of South America.
|
Market Players Covered
|
Bioha Laboratories (South Korea), Bohus BioTech AB (Sweden), Contura Ltd.(Switzerland), Laboratoires VIVACY (France), Merz Pharma (Germany), Prollenium Medical Technologies (Canada), Zhejiang Jingjia Medical Technology Co., LTD (China), Allergan (a subsidiary of AbbVie Inc.)(Ireland), Luminera (Israel), Medytox (South Korea), ADODERM GmbH (Germany), Azul Skin Health (U.S.), Bioxis pharmaceuticals (France), Croma Deutschland GmbH (Austria), Sinclair Pharma (U.K.), Suneva Medical (U.S.), dr. brandt skincare (U.S.), DRMTLGY LLC (U.S.), Galderma (Switzerland), Johnson & Johnson Services, Inc.(U.S.), Krasr (U.S.), Mary Kay Inc.(U.S.), Rodan & Fields (U.S.), Teoxane SA (Switzerland), Dermaroller GmbH (Germany), Alma Lasers (Israel), BIOPLUS CO., LTD.(South Korea), BISON MEDICAL (South Korea), CHUNGWOO Medical Co., Ltd. (South Korea), Fotona (Slovenia), HUMEDIX.CO.LTD (South Korea), Weyergans High Care AG (Germany) and SCULPT Luxury Dermal Fillers LTD (U.K.)
|
Data Points Covered in the Report
|
In addition to the insights on market scenarios such as market value, growth rate, segmentation, geographical coverage, and major players, the market reports curated by the Data Bridge Market Research also include depth expert analysis, patient epidemiology, pipeline analysis, pricing analysis, and regulatory framework.
|
Segment Analysis:
The global non-surgical procedures market is segmented on the basis of product type, material type, gender, usability, indication, procedure, practicians, service provider, and distribution channel.
- On the basis of product type, the non-surgical procedures market is segmented into injectable, non-injectable, facial rejuvenation, nonsurgical skin tightening, microdermabrasion, laser skin resurfacing, and others. The injectable segment dominates the non-surgical procedures market with a market share of 68.39%, owing to its capacity to enhance medication adherence and ensure rapid absorption
In 2023, the injectable segment of the product type segment dominates the global non-surgical procedures market
The injectable segment dominates the non-surgical procedures market with a market share of 68.39%, owing to its capacity to enhance medication adherence and ensure rapid absorption. Additionally, a preference among a majority of doctors and medical staff for injectable non-surgical products over alternative options contributes to the segment's prominence in the market.
- On the basis of material type, the non-surgical procedures market is segmented into natural and synthetic. The natural segment asserts market dominance, capturing an 84.4% share, attributed to its ability to deliver immediate and visible results. Furthermore, natural materials play a vital role in retaining significant amounts of water, filling existing wrinkles to diminish their appearance, and contributing to the prevention of wrinkle development
- On the basis of gender, the non-surgical procedures market is segmented into male and female. The female segment dominates the non-surgical procedures market with an 85.10% market share, primarily because a significant majority of women prefer non-surgical procedures compared to their male counterparts
In 2023, the female segment of the gender segment dominates the global non-surgical procedures market
The female segment dominates the non-surgical procedures market with an 85.10% market share, primarily because a significant majority of women prefer non-surgical procedures compared to their male counterparts. Additionally, the female population expresses substantial concerns about their appearance, further contributing to the segment's dominance in the market.
- On the basis of usability, the non-surgical procedures market is segmented into professional use, and direct patient. The professional use segment holds market dominance with an 80.77% share, driven by the increasing healthcare expenditure in both developed and developing nations
- On the basis of indication, the non-surgical procedures market is segmented into skin lightening, facial aesthetic, aesthetic implantation, body contouring, reconstructive, and others. The facial aesthetic segment commands a leading market share of 49.13% in the non-surgical procedures market, reflecting a strong preference for non-invasive facial enhancements and aesthetic procedures
- On the basis of procedure, the non-surgical procedures market is segmented into body care, face care, and skin care. The face care segment leads the market with a dominating share of 72.32%, attributed to its effectiveness in preventing acne, addressing wrinkles, and promoting optimal skin health
- On the basis of particians, the non-surgical procedures market is segmented into dermatologists, aesthetic doctors, plastic surgeons, independent aesthetic professionals, and others. The dermatologists segment commands a market dominance of 52.91%, driven by the prevalent preference of the majority for dermatology clinics as the preferred choice for skin treatments
- On the basis of service provider, the non-surgical procedures market is segmented into hospitals, medical spas and beauty centers, cosmetic centers, dermatology clinics, homecare setting, and others. The dermatology clinics segment holds a dominant market share of 35.58%, primarily due to factors such as the increasing prevalence of dermatology clinics in developing economies
- On the basis of distribution channel, the non-surgical procedures market is segmented into direct tender and retail sales. The direct tender segment commands a market dominance of 75.50%, primarily because a majority of medicines are acquired through direct tenders
Major Players
Data Bridge Market Research recognizes the following companies as the global non-surgical procedures market players in global non-surgical procedures market are Bioha Laboratories (South Korea), Bohus BioTech AB (Sweden), Contura Ltd.(Switzerland), Laboratoires VIVACY (France), Merz Pharma (Germany), Prollenium Medical Technologies (Canada), Zhejiang Jingjia Medical Technology Co., LTD (China).
Market Developments
- In September 2020, Croma Deutschland GmbH unveiled a strategic joint venture with China National Biotech Group Company Ltd. The collaboration aims to market Croma's premium Hyaluronic Acid Filler, Princess Volume, and other aesthetic products in China and Hong Kong. The primary objective of this collaboration is to leverage the expertise of both entities to expand the market presence and distribution of Croma's aesthetic offerings in the rapidly growing Chinese market
- In September 2020, Suneva Medical, Inc. disclosed an exclusive strategic partnership for the marketing and distribution of Neauvia North America's Plasma IQ across North America. This partnership is poised to expedite Suneva Medical's long-term growth trajectory, solidifying its market leadership. The exclusive partnership strategically positions both companies to capitalize on the demand for Plasma IQ, enhancing their collective presence in the North American aesthetic and medical aesthetics market
- In November 2020, Mary Kay Inc. reinforced its commitment to scientific innovation and education by providing educational grants in collaboration with IMCAS academy. This strategic initiative not only demonstrates Mary Kay's dedication to advancing knowledge in the industry but also enhances the company's market presence by fostering collaboration that contribute to the growth and education of professionals in the aesthetic and dermatological fields
Regional Analysis
Geographically, the countries covered in the global non-surgical procedures market report are U.S., Canada and Mexico in North America, Germany, France, U.K., Netherlands, Switzerland, Belgium, Russia, Italy, Spain, Turkey, Rest of Europe in Europe, China, Japan, India, South Korea, Singapore, Malaysia, Australia, Thailand, Indonesia, Philippines, Rest of Asia-Pacific (APAC) in the Asia-Pacific (APAC), Saudi Arabia, U.A.E, South Africa, Egypt, Israel, Rest of Middle East and Africa (MEA) as a part of Middle East and Africa (MEA), Brazil, Argentina and Rest of South America as part of South America.
As per Data Bridge Market Research analysis:
North America is the dominant region in the global non-surgical procedures market during the forecast period 2023-2030
North America dominates the non-surgical procedures market, driven by substantial market share and revenue. This trend is anticipated to persist, fueled by the availability of FDA-approved wound debridement devices and increasing healthcare spending. The region benefits from favorable health remuneration policies, a surge in chronic wounds, and a growing elderly population. These factors collectively contribute to a sustained growth trajectory in the non-surgical procedures market within North America during the forecast period.
Asia-Pacific is expected to dominate the global non-surgical procedures market in the forecast period 2023-2030
Asia-Pacific is expected to dominate the non-surgical procedures market from 2023 to 2030, driven by a surge in insurance payers. The region's burgeoning private healthcare sector and heightened public awareness contribute to the accelerated market growth. The increasing accessibility to non-surgical procedures, supported by a rising number of insurance options, positions Asia-Pacific as a key growth hub in the forecast period, reflecting the region's evolving healthcare landscape and growing emphasis on non-invasive medical interventions.
For more detailed information about the global non-surgical procedures market report, click here – https://www.databridgemarketresearch.com/fr/reports/global-non-surgical-procedures-market